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Highlights 30 
 CS: TPP microparticles were prepared using an experimental design 31 
 Variable factors were pH, ionic strength and CS: TPP ratio 32 
 Physical properties ([], -potential and D[4,3]) were measured 33 
 Equations were generated to predict physical properties of the microparticles  34 
 Potential to design tuneable CS-TPP microparticles for specific applications 35 
  36 
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Abstract 37 
Chitosan (CS) is a natural cationic polymer obtained by the partial N-deacetylation of chitin. 38 
Chitosan microparticles can be prepared by cross-linking with tripolyphosphate (TPP) via the 39 
ionic interaction between positively charged amino groups (CS) and negatively charged 40 
counter ions (TPP). This can be controlled by the charge density of CS and TPP, which depend 41 
on the pH and ionic strength of the solution. The purpose of this study is to investigate the 42 
combined effects of three independent variables (pH, ionic strength and CS: TPP ratio) on three 43 
important physico-chemical properties (viscosity, zeta potential and particle size) during the 44 
preparation of microparticles. CS: TPP microparticles were prepared using experimental 45 
design and equations were generated and used to predict relative viscosity, zeta potential and 46 
particle size under different conditions. This gives us the ability to design tuneable CS-TPP 47 
microparticles with desired size for specific pharmaceutical or forensic applications e.g. latent 48 
fingerprint visualisation. 49 
 50 
Keywords: Chitosan-Tripolyphosphate Microparticles; Ionic gelation; Experimental design 51 
  52 
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1. Introduction 53 
Chitosan refers to a family of linear copolymer polysaccharides consisting of β (1-4)-linked 2-54 
amino-2-deoxy-D-glucopyranose (D-glucosamine) and 2-acetamido-2-deoxy-D-glucose (N-55 
acetyl-D-glucosamine) units with different fractions of acetylated units [1]. An acetyl group 56 
may be present on some units (N-acetyl- D-glucosamine), which determines the degree of 57 
deacetylation (DD). Moreover, the DD of commercial chitosan is approximately 66 - 95 %, 58 
and the molecular weight (MW) approximately 10000 – 1000000 g/mol [2]. The structural units 59 
of chitosan have one reactive primary amino group (-NH2) on the C-2 position of each D-60 
glucosamine unit, and two reactive free hydroxyl groups (-OH) for each C-6 and C-3 position 61 
building unit (glucosamine and N-acetyl-D-glucosamine). These groups (both amino and 62 
hydroxyl) can be modified to obtain different chitosan derivatives, and provide opportunities 63 
for chemical modification to impart useful physicochemical properties and distinctive 64 
biological functions [3].  In addition, the advantage of chitosan over other polysaccharides is 65 
that its chemical structure allows specific modifications at the C-2 position without too many 66 
difficulties [4]. Chitosan has been investigated widely for its potential in the development of 67 
drug delivery systems and pharmaceutical applications [5] and more recently for its forensic 68 
applications [6].   69 
 70 
In latent fingerprint visualisation it is now accepted that particles adhere to fingermarks due to 71 
the mechanical attraction with the oily subcutaneous residues [7]. The factors with influence 72 
this interaction are particle size, particle charge, particle shape and relative surface area [7, 8] 73 
all of which are controlled by processing parameters such as chitosan concentration, pH and 74 
ionic strength of the dissolution media, temperature of cross-linking, stirring rate, etc [9].  75 
 76 
Various techniques have been developed to prepare chitosan micro/nanoparticles, such as ionic 77 
gelation, emulsion droplet, spray drying, coacervation and self-assembly chemical 78 
modification [10].  Among those methods, the ionic gelation method (also known as ionotropic 79 
gelation) with the non-toxic multivalent polyanion tripolyphosphate (TPP) is the most widely 80 
used approach to physical cross-linking. Ionic cross-linking can occur inside the network via 81 
interactions between the negative charges of the cross-linker such as TPP and the positively 82 
charged amino groups of chitosan molecules [11-14]. This method is advantageous as the 83 
reaction is simple and the conditions are relatively mild and do not require the use of organic 84 
solvents or high temperatures [1, 15]. Other advantages from the point of view of drug delivery 85 
and latent fingerprint enhancement are that particle size and (positive) charge can be easily 86 
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controlled and microparticle formulations have previously demonstrated the ability to associate 87 
with peptides, proteins [16] and with subcutaneous secretions in fingerprints [6]. 88 
 89 
Knowledge of viscosity, zeta potential, particle size and shape has an influence on potential 90 
applications of chitosan-TPP microparticles in drug delivery [9] or in forensic applications [6]. 91 
It is therefore the purpose of the present study is to investigate the systematic manipulation of 92 
three independent processing parameters (pH, ionic strength and CS: TPP ratio) on three 93 
important physico-chemical properties (relative viscosity, zeta potential and particle size) 94 
during the preparation of chitosan-TPP (CS-TPP) microparticles. This will then enable the use 95 
of mathematical models obtained to predict the relative viscosity, zeta potential (net surface 96 
charge) and particle size under different conditions to obtain predicable and programmable 97 
microparticle properties in relation to, for example, latent fingerprint enhancement, drug 98 
release kinetics or mucoadhesion. 99 
 100 
2. Materials and Methods 101 
2.1.  Materials 102 
Chitosan of medium molecular weight (M ∼295 000 g/mol) was obtained from Sigma–103 
Aldrich (Gillingham, UK) and reported to have an average degree of deacetylation (DD) of 104 
∼75–85%. Glacial acetic acid, sodium acetate trihydrate and tripolyphosphate (TPP) sodium 105 
salt were obtained from Sigma–Aldrich (Gillingham, UK) and red food colouring was from 106 
Silver Spoon (Peterborough, UK). All materials were used without any further purification.  107 
 108 
2.2.  Sample preparation 109 
Nine different acetate buffers (AB) including AB-1, AB-2, AB-3, AB-4, AB-5, AB-6, AB-7, 110 
AB-8, and AB-9 were prepared (Table 1) in order to investigate the effect of three independent 111 
variables: pH value, ionic strength and volumetric ratio of chitosan to TPP on the physico-112 
chemical properties of CS-TPP microparticles.  113 
 114 
  115 
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Table 1. Acetate buffers of varying ionic strength and pH. Buffers AB-1 to AB-9 were used to 116 
create generate model equations and buffer AB-10 to AB-13 were used in model validation. 117 
Acetate buffer (AB) pH Ionic strength (IS) 
AB-1 3.3 0.1  M 
AB-2 3.3 0.3  M 
AB-3 3.3 0.5  M 
AB-4 4.3 0.1  M 
AB-5 4.3 0.3  M 
AB-6 4.3 0.5  M 
AB-7 5.3 0.1  M 
AB-8 5.3 0.3  M 
AB-9 5.3 0.5  M 
 
AB-10 3.8 0.2  M 
AB-11 3.8 0.4  M 
AB-12 4.8 0.2  M 
AB-13 4.8 0.4 M 
 118 
2.2.1. Preparation of chitosan and TPP samples with different ionic strengths and pH 119 
value  (Acetate buffers AB-1 to AB-9) 120 
Nine different chitosan solutions were prepared by dissolving 2 g of chitosan powder in 1 L of 121 
acetate buffers (AB-1 to AB-9) to prepare chitosan solutions (2.0 mg/mL). The chitosan 122 
solutions were stirred overnight at room temperature using a magnetic stirrer. The TPP powder 123 
(1.680 g) was dissolved in 2 L of the acetate buffers (AB) to prepare nine samples of TPP 124 
solution (0.84 mg/mL) [17, 18]. 125 
 126 
2.2.2. Preparation of CS: TPP microparticles 127 
To prepare the CS:TPP microparticles, an appropriate volume of the TPP solution was added 128 
drop wise to the appropriate volume of the chitosan solution make seven ratios of CS: TPP 129 
microparticles (6:1, 4:1, 2:1, 1:1, 1:2, 1:2, 1:4 and 1:6), and the samples were then stirred at 130 
600 rpm for 60 minutes at room temperature. The resultant microparticles spontaneously 131 
formed due to the ionic crosslinking of chitosan by sodium tripolyphosphate. Then 30 drops (~ 132 
2 mL) of red dye added to all ratios to make the particles clearly visible and more amenable in 133 
latent fingerprint visualisation. The resultant microparticles were left standing overnight at 134 
room temperature before being subjected to further analysis. 135 
 136 
  137 
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2.2.3. Model validation (prediction method)  138 
Chitosan solutions were prepared by dissolving 2 mg/mL of polymer in a further four different 139 
acetate buffers (AB-10, AB-11, AB-12 and AB-13) (Table 1) and TPP solutions were prepared 140 
by dissolving TPP at a concentration of 0.84 mg/mL in the same acetate buffers (AB-10, AB-141 
11, AB-12 and AB-13). The resultant solutions were as in section 2.2.2 to give CS: TPP volume 142 
ratios (v/v) of 6: 1, 4: 1, 2: 1, 1: 1, 1: 2, 1: 4 and 1: 6 respectively. 143 
 144 
2.3.  Characterisation of chitosan microparticles 145 
2.3.1. Fourier transform infrared (FTIR) spectroscopy 146 
FTIR spectra of chitosan, TPP and chitosan microparticles were recorded using a Fourier 147 
transform infrared spectrophotometer (Thermo Nicolet 380 FT-IR spectrometer, Thermo 148 
Electron Corporation), operating from 4000 to 500 cm−1. 149 
 150 
2.3.2.  Powder X-Ray diffraction (XRD) study 151 
A crystallinity study was carried out by comparing XRD spectrum of microparticles using 152 
Bruker AXS diffractometer (D2 PHASER) with Cu Kα radiation to characterise chitosan, TPP 153 
and CS/TPP microparticles. The data was recorded at 2θ range of 5° to 100° at a scanning rate 154 
of 4°/min.  155 
 156 
2.3.3. Determination of relative viscosities 157 
All rheological measurements (solutions and reference solvents) were performed using a 158 
Bohlin Gemini HR Nano Rheometer (Malvern Instruments, Worcester-shire, UK) using 1 mm 159 
gap and 55 mm parallel plate geometry at a constant shear rate of 500 s-1 under precise 160 
temperature control (25.0 ± 0.1◦C). All measurements were performed in triplicate.  161 
 162 







0

 rel   (1) 163 
 164 
where is the average (n = 3) viscosity of the CS: TPP microparticles and, o is the viscosity 165 
for the appropriate acetate buffer [19]. 166 
 167 
  168 
8 
 
2.3.4. Determination of zeta potential 169 
Zeta potential was measured for each volume ratio using a Malvern Zetasizer NANO-Z 170 
(Malvern Instruments Limited, Malvern, UK). All Measurements were performed in the 171 
appropriate buffers in triplicate by using a folded capillary cell at 25.0 ± 0.1 oC and refractive 172 
index of the CS: TPP microparticles was set at 1.6 - 1.8 [20] and no significant effect of 173 
refractive index was identified. Each data value is an average of three measurements with a 174 
refractive index of 1.8. 175 
 176 
2.3.5 Determination of particle size 177 
The particle size distributions of the resultant chitosan particles were measured directly by a 178 
dynamic light scattering using a Malvern Mastersizer 2000 (Malvern Instruments Ltd., 179 
Malvern, UK).The microparticles were dispersed in deionized water. Refractive index of 180 
particles and dispersion medium (water) was set to 1.8 (see section 2.3.4) and 1.330, 181 
respectively. The size was described using the volume-weighted mean diameter D[4,3]. The 182 
intensity of scattered light was transformed into the diffusion factor, the mean value of 10 183 
measurements was obtained and each formulation and was repeated three times. 184 
 185 
2.3.6. Scanning electron microscopy (SEM) 186 
The surface microparticle morphology was characterised using scanning electron microscopy 187 
(SEM). The microparticles were vacuum dried, coated with gold palladium and observed 188 
microscopically (JEOL JSM 6060 LV - Oxford instruments, Abingdon, UK). Images were 189 
taken by applying an electron beam accelerating voltage of 20 kV.  Images were then analysed 190 
using Image J software (version 1.42q, National Institute of Health, Bethesda, USA) to estimate 191 
particle surface areas. 192 
 193 
3. Results and Discussion 194 
3.1. FTIR analysis 195 
The FTIR spectrum of pure TPP (Figure 1a) showed characteristic bands at 1217 cm−1 which 196 
indicates P= O stretching [21], 1138 cm−1 which indicates symmetrical and asymmetric 197 
stretching vibration of the PO2 groups , 1094 cm
−1  which indicates symmetric and asymmetric 198 
stretching vibration of the PO3 groups and 892 cm
−1 (P- O- P) asymmetric stretching [22]. As 199 
ca be seen in Figure 1b the spectrum of CS exhibits characteristic absorption bands at 3424 200 
cm−1 indicates the combined broad non-symmetric band of the -NH and -OH group stretching 201 
vibration of functional groups involved in hydrogen bonds, and the peak at 2873 cm−1 indicates 202 
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the –CH stretching vibration  [21, 23]. The peak at 1650 cm−1 indicates C=O stretching in 203 
amide I vibration group (CONH2), and 1560 cm
−1 which indicates N-H deformation  in amide 204 
II group vibration (NH2) [24]. Peaks at 1377 cm
−1 and 1322 cm−1 might be attributed to O–H 205 
deformation of –CH2–OH and –CH–OH, and absorption bands at 1151 cm−1 indicates 206 
asymmetric bridge oxygen (C–O–C) stretching [24]. 207 
 208 
Figure 1. FTIR spectrum of (a) TPP, (b) CS, (c) CS: TPP (6:1), (d) CS: TPP (4:1), (e) CS: TPP 209 
(2:1), (f) CS: TPP (1:1), (g) CS: TPP (1:2), (h) CS: TPP (1:4), (i) CS: TPP (1:6) in buffer AB-210 
1. 211 
 212 
The CS: TPP particles were characterized through FTIR spectroscopy, and the spectra are 213 
presented in Figures 1c – 1i. Crosslinking process in the spectra of all CS:TPP ratios samples 214 
the band of 3424 cm−1 becomes wider,  this indicates that hydrogen bonding is enhanced [25]. 215 
In addition in microparticles the band of 1650 cm−1 disappears and there appears a new band 216 
at 1635 cm−1. This band can be assigned to anti-symmetric deformation N‑H vibrations in 217 
NH3+ ion. The 1560 cm−1 peak in pure chitosan shifts to a new sharp peak at 1532 cm−1 [25]. 218 
These two new peaks as mentioned above (1635 cm−1 and 1535 cm−1) show  that a the linkage 219 
between the ammonium ions and phosphate ions [26]. In other words, the new NH3+–PO- bond 220 
is formed due to one hydrogen atom of the amino group in chitosan is substituted by the 221 
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phosphate group. It further provides that the amino group is the only reactive functional group 222 
chitosan. Moreover, the characteristic peaks of the hydroxyl groups at 1377 cm-1 and 1322 cm-223 
1 mentioned above do not change [24]. The cross-linked microparticles also show a new peak 224 
at 1217 cm-1 which may be attributed to the  P=O stretching from TPP [27]. Therefore clearly 225 
indicating that the protonated amino groups of chitosan are linked with negatively charged 226 
tripolyphosphate groups of TPP, clearly demonstrating the formation of CS: TPP particles. 227 
 228 
3.2. Crystallographic characterisation  229 
Crystallographic structure of chitosan powder and chitosan microparticles were determined by 230 
X-Ray Diffraction (XRD). The XRD spectra of the chitosan microparticles were characteristic 231 
of amorphous structures. As can be seen in Figure 2 there are two strong characteristic peaks 232 
in the diffractogram of chitosan powder at 2 θ = 10° (amine I “–N-CO-CH3” of chitosan)  and 233 
2 θ = 20° (amine II “–NH2” of chitosan), indicating the some degree of crystallinity of chitosan 234 
chains [28]. The peak at 10° is due to the integration of water molecules into the hydrated 235 
chitosan crystal structure and the latter peak at 20° is assigned to the crystal lattice of the 236 
chitosan orthorhombic unit cell (110) [29], furthermore there is no indication of impurities in 237 
the chitosan formulation [30]. It is known that the width of X-ray diffraction peak is related to 238 
the size of crystallite and an increase in the amorphous nature of the material [31]. Imperfect 239 
crystals usually lead to a broadened peak [32]. After ionic cross-linking with TPP, a shift of 240 
peak positions, significant reduction in the intensity of characteristic peaks of chitosan (at 2  241 
= 20°), and broadening of peaks were observed, reflecting the destruction of the native chitosan 242 
packing structure [33]. Figure 2 also highlights similarity between the CS: TPP ratios 2:1, 1:1, 243 
1:2, 1:4 and 1:6. Therefore the broad peak of the chitosan microparticles is due to ionic cross-244 
linking interaction between amino groups on chitosan and the TPP, which is known to destroy 245 
the crystalline structure of chitosan [33]. Integration of the two crystalline peaks (2  = 10 and 246 
20°) as a proportion of the total integrated area gives an approximate estimate of the degree of 247 
crystallinity in each of the samples. Based on this calculation the degree of crystallinity of the 248 
native chitosan is ~ 30 % and the degrees of crystallinity of the TPP-chitosan microparticles 249 
are all ~10 %, this is almost entirely due to the decrease in the chitosan orthorhombic unit cell 250 
reflection (110) at ~ 20°. Other than for 6:1 and 4:1 the reflection (020) at ~ 10° remains 251 
unchanged during ionotropic gelation with TPP. Changes in chitosan crystallinity is important 252 
in terms of polymer degradation, tensile strength, moisture content, cell responses in in vivo 253 
applications and contact angles which are important during hydration. All of these are factors 254 
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are important to consider when developing novel chitosan-based formulations for forensic or 255 
pharmaceutical applications. 256 
 257 
 258 
Figure 2. X-ray diffraction pattern of chitosan and of CS: TPP microparticles of different ratios 259 
in buffer AB-1. Only the diffraction pattern from 2 = 5 - 40° is shown for clarity. 260 
 261 
The cross linking of chitosan with a higher concentrations of TPP shows less intense and 262 
broader crystalline peaks (6:1 and 4:1) which may be due to a greater amorphisation as 263 
compared with those of less TPP 2:1, 1:1, 1:2, 1:4 and 1:6 [28]. The distinct differences in the 264 
diffractogram of chitosan and cross-linked chitosan might be attributed to chemical 265 
modification in the arrangement of molecules in the crystal lattice [26] and this is also in 266 
agreement with FT-IR as to the absence of “native” chitosan.  267 
 268 
3.3. Relative viscosity and zeta potential for varying chitosan solutions 269 
Chitosan when in solution is a polycation which is influenced by the presence of electrolytes 270 
[34]. Thus, the effect of ionic strength and pH value on nine different solutions of chitosan was 271 
studied. It can be seen from Figure 3A that the relative viscosity of nine chitosan solutions, 272 
with fixed pH including AB-1, AB-2 and AB-3; AB-4, AB-5 and AB-6; AB-7, AB-8 and AB-273 
9 decreased with increasing ionic strength solution.  274 
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Chain flexibility of chitosan molecules in solution can be manipulated by using chitosan with 275 
differing solution pH and/or ionic strength.  Furthermore, it is known that in acidic media the 276 
amino groups of chitosan, –NH2, are protonated to –NH3+ groups. This causes electrostatic 277 
repulsion between chitosan molecules; meanwhile, there also exists inter-chain hydrogen 278 
bonding interactions between chitosan molecules. The hydrogen bonding occurs between the 279 
amino and hydroxyl groups [35].  280 
 281 
In low ionic strength solutions (0.1 M), the intramolecular electrostatic repulsion effect, also 282 
called the third electroviscous effect, dominates in which the chitosan molecule exists in an 283 
extended conformation [35, 36]. Therefore, more inter-molecular hydrogen bonding occurs in 284 
low ionic strength solution [37]. This causes a high resistance to the flow or mobility of the 285 
polymer molecules and consequently a high relative viscosity is observed. However, in high 286 
ionic strength solutions (0.5 M), the concentration of acetate ions (CH3COO
-) is raised which 287 
neutralises more -NH3
+ groups. This leads to less dissolution of chitosan and weaker 288 
intermolecular electrostatic repulsion, causing the chitosan polymer chains to become more 289 
contracted and lowers the resistance to the flow or mobility of the polymers, resulting in a 290 
lower relative viscosity [38].  In addition, the relative viscosity of chitosan also decreased with 291 
increasing pH in solutions with fixed ionic strength. The number of positive charges on CS at 292 
I.S 0.1 M will be greater at pH 3.3 of the solvent, leading to a higher degree of expansion of 293 
chitosan and a rigid conformation due to electrostatic repulsions [39]. Information on chain 294 
expansion of chitosan used in the formulation of microparticles enables the possibility to better 295 
control microparticle properties by selecting suitable preparation conditions or starting polymer 296 
[40]. Because of this, the chitosan molecules disrupt the streamlining of the flow and increases 297 
viscosity, which will have an influence on the size (and shape) of any chitosan microparticles 298 
formed under these conditions [41]. 299 
 300 
Zeta potential measurement is important to gain knowledge on the surface charge. This charge 301 
can affect the interaction between chitosan polymer chains in phenomena such as swelling , in 302 
the interaction with TPP during gelation [42] or during the interaction with oily subcutaneous 303 
residues [7]. The ionic strength and pH value of the chitosan solution affect this interaction. 304 
  305 
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The effect of pH value and ionic strength of the chitosan solution on zeta potential may be seen: 306 
 307 
(i) At variable pH value and fixed ionic strength 308 
It can be seen from Figure 3B that the zeta potential decreases as the pH value increases from 309 
3.3 to 5.3. At pH 3.3, the primary amine groups -NH2 of chitosan are more strongly protonated 310 
as -NH3
+ in acetate buffer solution and therefore increased zeta potential. On the other hand, at 311 
an increased pH value of 5.3 the –NH3+ on the chitosan molecules were more neutralised 312 
resulting in a decreased zeta potential. 313 
 314 
(ii) At the fixed pH value and variable ionic strength (0.1, 0.3 and 0.5 M) 315 
It can be seen from Figure 3B that the zeta potential decreased with an increase in the ionic 316 
strength from 0.1 M to 0.5 M. At ionic strength 0.1 M, the primary amine groups -NH2 of 317 
chitosan are protonated as -NH3
+ in acetate buffer solution and therefore an increased zeta 318 
potential is seen. Conversely, with an increased ionic strength at 0.5 M, the –NH3+ on the 319 
chitosan molecules were charge screened by acetate ions (CH3COO
-) leading to a decreased 320 
zeta potential. This is important in terms of the conformation of chitosan chains and how that 321 
might influence their interactions with TPP polyanions during ionotropic gelation where the 322 
change in zeta potential of chitosan (and indeed all polyelectrolyte biopolymers) can be used 323 
to estimate chain stiffness [36].  324 
 325 
 326 
Figure 3. Relative viscosities (A) and zeta potentials (B) of nine different chitosan solutions 327 
(using AB-1 to AB-9) at varying ionic strength and pH values at 25.0 ± 0.1 oC (mean ± STDEV, 328 
n = 3). 329 
 330 
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3.4. Analysis of different ratios of CS: TPP microparticles with different acetate 331 
buffers 332 
In this study CS: TPP microparticles formed by ionotropic gelation, were prepared at various 333 
ratios, (loaded with red dye for visualisation purposes), by the mixing CS solution with TPP 334 
solution under stirring. The particles formed at each ratio were shown to have different 335 
chemical and physical properties (Figure 4 A-G). As can be seen in Figure 4, microparticles 336 
prepared with AB-12 at the higher CS: TPP ratios and therefore at higher viscosity and surface 337 
charge had more porous surfaces than those of microparticles prepared with the lower CS: TPP 338 
ratios which had irregular angular surfaces, this is expected to have an influence strength of 339 
interaction and therefore integrity of the particle “walls” and therefore their size and shape [43]. 340 
The availability of TPP is of course limited at high chitosan ratios and in excess in those with 341 
lower chitosan ratios and this influences the cross-linking density which again has an effect on 342 
size, shape and morphology of the particles [43]. Furthermore, although it may appear as 343 
though some of the particles are fragments of precipitated chitosan this is not the case as this 344 
inconsistent with both the FT-IR and XRD data above. In terms of potential applications of 345 
non-spherical  particles it has been previously reported that flake-like metal particles 346 
(aluminium, copper, etc.) are more effective than spherical particles in latent fingerprint 347 
development [8] due to increased surface: volume ratios [7], therefore samples with a 2:1 CS: 348 
TPP ratio were used for further forensic studies in latent fingerprint visualisation with 349 
encouraging results (Hejjaji, Smith and Morris, submitted), this will depend on total particle 350 
surface area, which ranges from ~7000 m2 (Figure 4D) to >30000 m2 (Figure 4A) and on 351 
the number of particles per unit area. In the case of the irregular particles previous research has 352 
shown that the shape of CS: TPP microparticles depends on the pH at which chitosan and TPP 353 
are mixed and the molecular weight (viscosity) of the chitosan [44], furthermore in terms of 354 
pharmaceutical applications irregular particles with angular features have been shown to 355 
decrease drug dissolution [45], have a higher drug loading efficiency [46], influence 356 
phagocytosis [47] and to have a greater probability of adhering to cancer cell surfaces [48] 357 
which suggests that CS: TPP microparticles formed in this way may be have potential in drug 358 
delivery formulations. Although due to the inherent difficulties in measuring particles with 359 
different morphologies the impact of shape has not been studied to a great extent. 360 
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 361 
Figure 4. Example SEM images at 20 kV of chitosan microparticles CS: TPP using AB-12 (A) 362 
6:1, (B) 4:1, (C) 2:1, (D) 1:1, (E) 1:2, (F) 1:4 and (G) 1:6. Where the scale bar is 100 m and 363 
the estimated total surface areas of the particles are approximately ~30000, 14000, 8000, 7000, 364 
8000, 32000 and 15000 m2, respectively. 365 
 366 
The relative viscosity of the CS: TPP microparticle suspension is shown in Figure 5A, which 367 
indicates that neither pH nor ionic strength have a large influence the relative viscosity at ratios 368 
CS: TPP 1:6, 1:4, 1:2, 1:1 and 2:1. It can be attributed to its lesser resistance towards flow due 369 
the relatively low charge on chitosan microparticles. At higher ratios (4:1; 6:1), the relative 370 
viscosity is higher with an increase in the CS: TPP ratio in the mixture. Moreover, at the fixed 371 
pH value and different ionic strength (0.1, 0.3 and 0.5 M), the relative viscosity increased with 372 
a decrease in ionic strength. This behaviour may arise because of the decrease in the repulsion 373 
force between charges for the solvent and polymers and not unsurprisingly is dominated by the 374 
amount of chitosan in the microparticles. 375 
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 376 
Figure 5A. Relative viscosities of CS: TPP microparticles solutions (using AB-1 to AB-9) at varying ionic strength and pH values at 25.0 ± 0.1 377 
oC (mean ± STDEV, n = 3). 378 
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 379 
Figure 5B. Zeta potentials of CS: TPP microparticles solutions (using AB-1 to AB-9) at varying ionic strength and pH values at 25.0 ± 0.1 oC 380 
(mean ± STDEV, n = 3). 381 
18 
 
 382 
Figure 5C. Particle size (D[4,3]) of CS: TPP microparticles solutions (using AB-1 to AB-9) at varying ionic strength and pH values at 25.0 ± 0.1 383 
oC (mean ± STDEV, n = 3). 384 
19 
 
The effect of ionic strength and pH value on the zeta potential of nine chitosan microparticle 385 
formulations was investigated as shown in Figure 5B. When chitosan and TPP were mixed 386 
with each other in an acetate buffer, they spontaneously formed microparticles (diameters were 387 
in the range 28-445 m) with an overall positive surface charge which are at least partially 388 
within the size range of particles which have been demonstrated to be effective in latent 389 
fingerprint visualisation ~1-50 m [8] and may have potential in pulmonary [40] or colonic 390 
drug delivery systems[49] . The more positively or negatively charged the particles, the more 391 
they repel each other and therefore at values of ± 30 mV are required for optimal stability [50]. 392 
As the CS: TPP ratio decreased from 6:1 to 1:6 the zeta potential values decreased from for 393 
example 36.4 mV to 5 mV in buffer AB-1 or from 13.5 mV to 3 mV in buffer AB-9 (Figure 394 
5B). It was also observed that with a decrease in the concentration of chitosan the appearance 395 
of the system changed from clear viscous liquid to milky dispersion prior to precipitation. 396 
 397 
It was demonstrated that, there was no significant difference in the zeta potential values of CS: 398 
TPP from 1:2 to 1:6, indicating neutralization of the protonated amino groups on the surface 399 
of chitosan microparticles and subsequent loss of repulsive force which led to precipitation of 400 
the particles. On the other hand, as the CS: TPP ratio increased from 1:2 to 6:1 the zeta potential 401 
increased almost linearly. The large positive surface charge due to the high degree of 402 
deacetylation and protonation causes the chitosan molecules to have a large number of potential 403 
cross-linking sites. The presence of higher positive charge on the particles indicated that free 404 
(non-cross-linked) amino groups remained on the particle surface [35, 51] which is consistent 405 
with an increased viscosity in solution.  406 
 407 
When the CS: TPP ratio was high at 6:1and 4:1 (the available quantity of TPP was small) the 408 
reaction solution was clear, indicating that the amount of phosphate groups was inadequate to 409 
lead to the full cross-linking with the chitosan amino groups [52]. As the CS: TPP ratio 410 
decreased from 6:1 to 1:1, the particle size decreased due to increased intramolecular and 411 
intermolecular cross-linking density between chitosan amino groups and the TPP groups 412 
(Figure 5C), this is also due to the decrease in viscosity (Figure 5A) which leads weaker 413 
networks and therefore assuming there is no change in shear forces (stirring rate was constant 414 
at 600 rpm in all cases) smaller particles [41]. It can be inferred that chitosan molecules were 415 
almost fully cross-linked at CS: TPP (1:1), which coincided with the smallest particle size range 416 
measured. As the CS: TPP ratio decreases further from 1:1 to 1:6 the particle size increased, as 417 
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more TPP molecules are involved in the formation of the microparticles. This increased 418 
concentration of TPP promotes aggregation due to inter-particle cross-linking (bridging 419 
effects) which leads to a lower surface charge density of the particles resulting in precipitation 420 
[52]. As we can see in Figure 4 the CS: TPP microparticles are in some cases non-spherical, 421 
with aspect ratios ranging from 1:1 to 13:1 and as particle size analysis treats particles as 422 
equivalent spheres there is potential for minor discrepancies in the absolute particle sizes, these 423 
are expected to be minimal although this will depend on the type of material being measured 424 
[53]. 425 
 426 
Using multiple regression analysis, the responses (relative viscosity, zeta potential and particle 427 
size) were correlated with the three variables studied using second-order polynomials. The 428 
coefficients of the model equation and their statistical significance were evaluated using 429 
Minitab® 17.1.0 software (Minitab Inc., Philadelphia, U.S.A.). The regression model for the 430 
responses to relative viscosity (Y1), zeta potential (Y2) and particle size (Y3) in terms of coded 431 
factors is given by Equations 2 - 4 respectively.  432 
 433 
Y1 = -0.251 + 0.575 X1 - 0.136 X2 + 0.3315 X3 - 0.0631 X1
2 + 0.008 X1X2 - 0.0676 X1X3 434 
+ 0.232 X2
2 - 0.178 X2 X3 + 0.01397 X3
2 + 0.0213 X1X2X3  (2) 435 
 436 
Y2 = -25.54 + 14.89 X1 - 35.8 X2+ 15.00 X3 - 1.812 X1
2 + 6.88 X1X2- 1.606 X1X3 437 
     + 16.5 X2
2 + 2.32 X2 X3 - 0.5282 X3
2 - 1.446 X1X2X3  (3) 438 
 439 
Y3 = 299 - 98.3 X1 - 271 X2- 9.9 X3 + 12.4 X1
2 + 54.5 X1X2+ 4.23 X1X3+ 167 X2
2 - 12.2 X2 X3 440 
+ 5.50 X3
2 + 7.1 X1X2X3  (4) 441 
 442 
The equations were applied the response, to describe the principal effects and interactions 443 
amongst the identified variables pH (X1), ionic strength (X2) and ratio (X3).  444 
 445 
The coefficients with one factor represent the effect of the particular factor, while the 446 
coefficients with two factors, three factors and those with second order terms represent the 447 
interaction between the two factors, three factors and quadratic effect, respectively. The 448 
positive sign in front of the terms indicates synergistic effect, while negative sign indicates 449 
antagonistic effect on the responses. 450 
 451 
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3.5. Model validation of relative viscosity, zeta potential and particle size 452 
Four different chitosan microparticles formulations were prepared in different acetate buffers 453 
including AB-10, AB-11, AB-12 and AB-13. The relative viscosities and zeta potential of the 454 
four chitosan microparticles were measured (Table 2). The regression equations were obtained 455 
for equations 2 - 4 which suggests the empirical relationship between the value of response and 456 
the independent variable. Therefore, the predicted values were calculated using mathematical 457 
model from equations 2 - 4. 458 
 459 
For validation of relative viscosity, zeta potential and particle size results, the experimental 460 
values of the responses were compared with that of the predicted values Table 2. Moreover, 461 
Table 2 indicates that ionic strength, pH and Chitosan: TPP ratio are suitable in predicting 462 
viscosity, zeta potential and particle size due to a high values of r2, (r2 = 0.91, r2 = 0.96 and 463 
0.86 respectively) and can therefore be used in future studies to design tuneable microparticles 464 
for specific applications.  465 
  466 
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Table 2. Observed (Exp.) responses and predicted (Pred.) values for relative viscosity (Y1), 467 
zeta potential (Y2) and particle size (Y3)  468 
Dependant Variables Y1 
Relative viscosity 
Y2 
Zeta potential (mV) 
Y3: 
Particle size [D4,3] 
(m) X1 
pH 
X2 
I.S. 
X3 
(CS:TPP) 
Ratio Exp. Pred. Exp. Pred. Exp. Pred. 
3.8 0.2 6:1 1.66 ± 0.01 1.85 35.2 ± 1.3 34.2 354 ± 40 351 
3.8 0.2 4:1 1.34 ± 0.01 1.46 29.7 ± 1.1 28.2 226 ± 21 223 
3.8 0.2 2:1 1.07 ± 0.01 1.18 19.0 ± 1.6 18.0 135 ± 6 139 
3.8 0.2 1:1 1.11 ± 0.01 1.08 11.8 ± 0.9 11.3 111 ± 3 113 
3.8 0.2 1:2 1.05 ± 0.01 1.04 8.5 ± 1.3 7.6 119 ± 2 104 
3.8 0.2 1:4 1.04 ± 0.01 1.03 6.1 ± 0.9 5.6 124 ± 3 101 
3.8 0.2 1:6 1.04 ± 0.01 1.02 5.8 ± 0.4 5.0 128 ± 6 100 
3.8 0.4 6:1 1.66 ± 0.01 1.74 32.6 ± 2.9 30.4 379 ± 49 376 
3.8 0.4 4:1 1.45 ± 0.01 1.38 27.0 ± 2.7 25.7 248 ± 41 242 
3.8 0.4 2:1 1.04 ± 0.01 1.15 17.0 ± 0.6 16.8 146 ± 5 152 
3.8 0.4 1:1 1.00 ± 0.01 1.07 10.0 ± 0.7 10.8 121 ± 2 123 
3.8 0.4 1:2 1.02 ± 0.01 1.04 8.0 ± 1.2 7.3 129 ± 5 113 
3.8 0.4 1:4 1.02 ± 0.01 1.03 6.0 ± 1.4 5.5 132 ± 4 109 
3.8 0.4 1:6 1.02 ± 0.01 1.02 4.3 ± 0.7 4.9 135 ± 5 108 
4.8 0.2 6:1 1.45 ± 0.01 1.50 21.3 ± 0.4 23.5 407 ± 50 404 
4.8 0.2 4:1 1.24 ± 0.01 1.24 19.9 ± 0.8 21.3 267 ± 31 265 
4.8 0.2 2:1 1.09 ± 0.01 1.08 14.3 ± 0.6 14.9 171 ± 4 169 
4.8 0.2 1:1 1.03 ± 0.01 1.05 9.7 ± 0.5 10.1 135 ± 2 138 
4.8 0.2 1:2 0.98 ± 0.01 1.04 8.0 ± 0.1 7.3 138 ± 2 126 
4.8 0.2 1:4 1.07 ± 0.01 1.04 6.9 ± 0.4 5.8 139 ± 2 122 
4.8 0.2 1:6 0.97 ± 0.01 1.04 4.8 ± 0.1 5.4 142 ± 6 120 
4.8 0.4 6:1 1.38 ± 0.01 1.42 18.6 ± 0.6 19.4 451 ± 31 445 
4.8 0.4 4:1 1.21 ± 0.01 1.18 17.3 ± 0.1 19.0 306 ± 29 300 
4.8 0.4 2:1 1.06 ± 0.01 1.06 10.3 ± 0.3 14.5 194 ± 11 196 
4.8 0.4 1:1 1.02 ± 0.01 1.04 9.0 ± 0.5 10.6 158 ± 8 161 
4.8 0.4 1:2 0.98 ± 0.01 1.05 6.8 ± 0.3 8.3 164 ± 10 147 
4.8 0.4 1:4 1.02 ± 0.01 1.05 5.7 ± 0.2 7.0 167 ± 23 141 
4.8 0.4 1:6 0.98 ± 0.01 1.05 4.2 ± 0.5 6.6 171 ± 15 139 
 469 
4. Conclusions 470 
In this study, chitosan microparticles of different morphologies were successfully formed by 471 
the ionotropic gelation method at different CS: TPP ratios and pH/Ionic strength conditions. 472 
The particles were characterized by relative viscosity, zeta potential, particle size, FTIR 473 
spectroscopy and XRD. Using experimental design, the relative viscosity, particle size and zeta 474 
potential of CS: TPP microparticles under different conditions could be predicted using the 475 
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mathematical models. The mathematical models obtained showed good relationships between 476 
independent variables (pH, ionic strength and CS: TPP ratio) and dependent variables (relative 477 
viscosity, zeta potential and particle size) for prediction. This gives us the ability to design 478 
tuneable CS-TPP microparticles for specific pharmaceutical or forensic applications more 479 
specifically latent fingerprint visualisation. 480 
 481 
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